View Single Post
Old 01-19-2011, 04:48 AM   #12
Unregistered
Guest
 
Posts: n/a
Re: NY Times article on stage IVs with stats and singling out her2+ breast

"We are learning more and more as to how the tumors get around the her2 blockage (her3, Egfr, IGFR1, Muc4, truncated her2, etc)

and another article I posted from U of Michigan shows we are discovering how the "metastatic niche" awakens the slumbering cancer stem cells and encourages metastasis"

How soon can it be learned enough to help the patients?
  Reply With Quote